(1->4)-beta-D-glucan multiple interactions ISO RGD:62254 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of S1PR3 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1352881 6480464 o, p'-DDT results in increased expression of S1PR3 mRNA CTD PMID:19371625 1,2-dimethylhydrazine decreases expression ISO RGD:62254 6480464 1, 2-Dimethylhydrazine results in decreased expression of S1PR3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:62254 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of S1PR3 mRNA] CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1352881 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of S1PR3 mRNA CTD PMID:20404318 17beta-estradiol decreases expression ISO RGD:1352881 6480464 Estradiol results in decreased expression of S1PR3 mRNA CTD PMID:19167446 , PMID:28711546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62254 6480464 Tetrachlorodibenzodioxin affects the expression of S1PR3 mRNA CTD PMID:20702594 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62254 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of S1PR3 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62254 6480464 Tetrachlorodibenzodioxin results in increased expression of S1PR3 mRNA CTD PMID:21889950 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62254 6480464 Tetrachlorodibenzodioxin results in decreased expression of S1PR3 mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:62254 6480464 2 more ... CTD PMID:20702594 4,4'-sulfonyldiphenol increases expression ISO RGD:62254 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of S1PR3 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1352881 6480464 [Decitabine co-treated with trichostatin A] affects the expression of S1PR3 mRNA CTD PMID:17189669 acetamide increases expression EXP 6480464 acetamide results in increased expression of S1PR3 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:1352881 6480464 Aflatoxin B1 results in increased expression of S1PR3 mRNA CTD PMID:22100608 Aflatoxin B2 alpha decreases methylation ISO RGD:1352881 6480464 aflatoxin B2 results in decreased methylation of S1PR3 3' UTR CTD PMID:30157460 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of S1PR3 mRNA CTD PMID:22406263 all-trans-retinoic acid decreases expression ISO RGD:1352881 6480464 Tretinoin results in decreased expression of S1PR3 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:62254 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of S1PR3 mRNA CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of S1PR3 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1352881 6480464 Antirheumatic Agents results in decreased expression of S1PR3 mRNA CTD PMID:24449571 apigenin multiple interactions EXP 6480464 Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of S1PR3 protein] CTD PMID:25557508 aristolochic acid A increases expression ISO RGD:1352881 6480464 aristolochic acid I results in increased expression of S1PR3 mRNA CTD PMID:33212167 belinostat decreases expression ISO RGD:1352881 6480464 belinostat results in decreased expression of S1PR3 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1352881 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of S1PR3 mRNA CTD PMID:27188386 benzo[a]pyrene increases expression ISO RGD:1352881 6480464 Benzo(a)pyrene results in increased expression of S1PR3 mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1352881 6480464 Benzo(a)pyrene results in increased methylation of S1PR3 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1352881 6480464 Benzo(a)pyrene affects the methylation of S1PR3 3' UTR CTD PMID:30157460 bisphenol A increases expression ISO RGD:1352881 6480464 bisphenol A results in increased expression of S1PR3 mRNA CTD PMID:19371625 bisphenol A multiple interactions ISO RGD:1352881 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of S1PR3 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:62254 6480464 bisphenol A results in increased expression of S1PR3 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of S1PR3 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of S1PR3 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:62254 6480464 bisphenol F results in increased expression of S1PR3 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:62254 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of S1PR3 mRNA CTD PMID:30951980 bleomycin A2 multiple interactions ISO RGD:62254 6480464 S1PR5 protein affects the reaction [Bleomycin results in increased expression of S1PR3 mRNA] CTD PMID:29033951 bleomycin A2 increases expression ISO RGD:62254 6480464 Bleomycin results in increased expression of S1PR3 mRNA CTD PMID:29033951 buta-1,3-diene decreases expression ISO RGD:62254 6480464 1, 3-butadiene results in decreased expression of S1PR3 mRNA CTD PMID:29038090 cadmium dichloride decreases expression ISO RGD:1352881 6480464 Cadmium Chloride results in decreased expression of S1PR3 mRNA CTD PMID:26472689 carbon nanotube increases expression ISO RGD:62254 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:1352881 6480464 S1PR3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chloroprene decreases expression ISO RGD:62254 6480464 Chloroprene results in decreased expression of S1PR3 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:62254 6480464 Chlorpyrifos results in increased expression of S1PR3 mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:62254 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of S1PR3 gene CTD PMID:20938992 cisplatin increases expression ISO RGD:1352881 6480464 Cisplatin results in increased expression of S1PR3 mRNA CTD PMID:27392435 coumestrol multiple interactions ISO RGD:1352881 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO RGD:1352881 6480464 Coumestrol results in decreased expression of S1PR3 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of S1PR3 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1352881 6480464 Cyclosporine results in decreased expression of S1PR3 mRNA CTD PMID:20106945 , PMID:27989131 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of S1PR3 mRNA CTD PMID:22406263 daidzein multiple interactions ISO RGD:1352881 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:1352881 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA CTD PMID:27424125 dexamethasone increases expression ISO RGD:1352881 6480464 Dexamethasone results in increased expression of S1PR3 mRNA CTD PMID:25047013 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of S1PR3 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:62254 6480464 Dibutyl Phthalate results in increased expression of S1PR3 mRNA CTD PMID:17361019 , PMID:21266533 diethylstilbestrol increases expression ISO RGD:1352881 6480464 Diethylstilbestrol results in increased expression of S1PR3 mRNA CTD PMID:19371625 dioxygen decreases expression ISO RGD:1352881 6480464 Oxygen deficiency results in decreased expression of S1PR3 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1352881 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1352881 6480464 Doxorubicin results in decreased expression of S1PR3 mRNA CTD PMID:29803840 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of S1PR3 mRNA CTD PMID:32289291 Enterolactone multiple interactions ISO RGD:1352881 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:1352881 6480464 entinostat results in decreased expression of S1PR3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1352881 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of S1PR3 mRNA CTD PMID:27188386 enzalutamide affects expression ISO RGD:1352881 6480464 enzalutamide affects the expression of S1PR3 mRNA CTD PMID:30940724 ethanol increases expression ISO RGD:62254 6480464 Ethanol results in increased expression of S1PR3 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:62254 6480464 Ethanol affects the expression of S1PR3 mRNA CTD PMID:30319688 fingolimod hydrochloride multiple interactions ISO RGD:1352881 6480464 Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR3 protein] CTD PMID:25980589 folic acid multiple interactions ISO RGD:62254 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of S1PR3 gene more ... CTD PMID:20938992 , PMID:22206623 fulvestrant multiple interactions ISO RGD:1352881 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of S1PR3 gene CTD PMID:31601247 genistein increases expression ISO RGD:1352881 6480464 Genistein results in increased expression of S1PR3 mRNA CTD PMID:19371625 genistein multiple interactions ISO RGD:1352881 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:1352881 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA CTD PMID:27424125 glucose decreases expression EXP 6480464 Glucose results in decreased expression of S1PR3 mRNA CTD PMID:22406263 glycitein multiple interactions ISO RGD:1352881 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:1352881 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA CTD PMID:27424125 L-methionine multiple interactions ISO RGD:62254 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of S1PR3 gene CTD PMID:20938992 lipopolysaccharide multiple interactions EXP 6480464 Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of S1PR3 protein] CTD PMID:25557508 lipopolysaccharide multiple interactions ISO RGD:1352881 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of S1PR3 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1352881 6480464 Lipopolysaccharides results in increased expression of S1PR3 mRNA CTD PMID:35811015 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of S1PR3 protein CTD PMID:25557508 methylisothiazolinone increases expression ISO RGD:1352881 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of S1PR3 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1352881 6480464 methylmercuric chloride results in increased expression of S1PR3 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1352881 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of S1PR3 mRNA CTD PMID:24399507 N-methyl-4-phenylpyridinium increases expression ISO RGD:1352881 6480464 1-Methyl-4-phenylpyridinium results in increased expression of S1PR3 mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression ISO RGD:62254 6480464 Diethylnitrosamine results in increased expression of S1PR3 mRNA CTD PMID:24535843 N-Nitrosopyrrolidine increases expression ISO RGD:1352881 6480464 N-Nitrosopyrrolidine results in increased expression of S1PR3 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1352881 6480464 Nickel results in increased expression of S1PR3 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:1352881 6480464 nickel sulfate results in increased expression of S1PR3 mRNA CTD PMID:22714537 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of S1PR3 mRNA, nitrofen results in decreased expression of S1PR3 protein CTD PMID:26543024 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of S1PR3 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:62254 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of S1PR3 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of S1PR3 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:1352881 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of S1PR3 mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1352881 6480464 panobinostat results in decreased expression of S1PR3 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1352881 6480464 Acetaminophen affects the expression of S1PR3 mRNA CTD PMID:25458485 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62254 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of S1PR3 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:62254 6480464 Phenobarbital affects the expression of S1PR3 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:62254 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of S1PR3 mRNA] CTD PMID:17950772 pirinixic acid decreases expression ISO RGD:62254 6480464 pirinixic acid results in decreased expression of S1PR3 mRNA CTD PMID:17950772 potassium chromate decreases expression ISO RGD:1352881 6480464 potassium chromate(VI) results in decreased expression of S1PR3 mRNA CTD PMID:22714537 potassium dichromate increases expression ISO RGD:62254 6480464 Potassium Dichromate results in increased expression of S1PR3 mRNA CTD PMID:23608068 propionic acid increases expression ISO RGD:1352881 6480464 propionic acid results in increased expression of S1PR3 mRNA CTD PMID:31526819 resveratrol increases expression ISO RGD:1352881 6480464 resveratrol results in increased expression of S1PR3 mRNA CTD PMID:19371625 resveratrol multiple interactions ISO RGD:1352881 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of S1PR3 mRNA CTD PMID:19167446 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1352881 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of S1PR3 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1352881 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:62254 6480464 Silicon Dioxide results in increased expression of S1PR3 mRNA CTD PMID:23221170 simvastatin increases expression ISO RGD:1352881 6480464 Simvastatin results in increased expression of S1PR3 mRNA CTD PMID:18612546 simvastatin decreases expression ISO RGD:1352881 6480464 Simvastatin results in decreased expression of S1PR3 mRNA CTD PMID:18981156 Soman increases expression EXP 6480464 Soman results in increased expression of S1PR3 mRNA CTD PMID:19281266 sphingosine 1-phosphate multiple interactions ISO RGD:1352881 6480464 Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR3 protein] more ... CTD PMID:18612546 , PMID:25980589 sphingosine 1-phosphate increases expression ISO RGD:1352881 6480464 sphingosine 1-phosphate results in increased expression of S1PR3 protein CTD PMID:25980589 temozolomide affects response to substance ISO RGD:1352881 6480464 S1PR3 mRNA affects the susceptibility to Temozolomide CTD PMID:16365179 tetrachloromethane increases expression ISO RGD:62254 6480464 Carbon Tetrachloride results in increased expression of S1PR3 mRNA CTD PMID:17341687 tetrachloromethane decreases expression ISO RGD:62254 6480464 Carbon Tetrachloride results in decreased expression of S1PR3 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of S1PR3 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of S1PR3 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1352881 6480464 torcetrapib results in increased expression of S1PR3 mRNA CTD PMID:23228038 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of S1PR3 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1352881 6480464 [Decitabine co-treated with trichostatin A] affects the expression of S1PR3 mRNA more ... CTD PMID:17189669 , PMID:27188386 trichostatin A decreases expression ISO RGD:1352881 6480464 trichostatin A results in decreased expression of S1PR3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A increases expression ISO RGD:1352881 6480464 trichostatin A results in increased expression of S1PR3 mRNA CTD PMID:24935251 troglitazone decreases expression ISO RGD:62254 6480464 troglitazone results in decreased expression of S1PR3 mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:1352881 6480464 troglitazone results in increased expression of S1PR3 mRNA CTD PMID:19140230 urethane increases expression ISO RGD:1352881 6480464 Urethane results in increased expression of S1PR3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:62254 6480464 Valproic Acid affects the expression of S1PR3 mRNA CTD PMID:17292431 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of S1PR3 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:62254 6480464 Valproic Acid results in increased expression of S1PR3 mRNA CTD PMID:24896083 valproic acid increases methylation ISO RGD:1352881 6480464 Valproic Acid results in increased methylation of S1PR3 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1352881 6480464 Valproic Acid results in increased expression of S1PR3 mRNA CTD PMID:24935251 valproic acid decreases expression ISO RGD:1352881 6480464 Valproic Acid results in decreased expression of S1PR3 mRNA CTD PMID:24935251 , PMID:28001369 vanadyl sulfate increases expression ISO RGD:1352881 6480464 vanadyl sulfate results in increased expression of S1PR3 mRNA CTD PMID:16330358 WIN 55212-2 increases expression ISO RGD:62254 6480464 (3R)-((2 more ... CTD PMID:12237329 zearalenone increases expression ISO RGD:1352881 6480464 Zearalenone results in increased expression of S1PR3 mRNA CTD PMID:19371625